Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve ...
Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a breakthrough in understanding the spread of oral squamous cell carcinoma ...
Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...
Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages ...
Therapy-related B-cell acute lymphoblastic leukemia (B-ALL), a rare form of acute lymphoblastic leukemia (ALL), may develop in patients receiving cytotoxic treatments for a prior malignancy, according ...
Clinical Trials Arena on MSN11d
PDS Biotechnology commences trial for head and neck squamous cell carcinomaPDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...
Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback